help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on October 8, 2009, doi:10.1164/rccm.200902-0190OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200902-0190OCv1
181/1/7    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Aguilar-Pimentel, J. A.
Right arrow Articles by Ollert, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aguilar-Pimentel, J. A.
Right arrow Articles by Ollert, M.
American Journal of Respiratory and Critical Care Medicine Vol 181. pp. 7-16, (2010)
© 2010 American Thoracic Society
doi: 10.1164/rccm.200902-0190OC


Original Article

Specific CD8 T Cells in IgE-mediated Allergy Correlate with Allergen Dose and Allergic Phenotype

Juan A. Aguilar-Pimentel1, Francesca Alessandrini2,3, Katharina M. Huster4,5, Thilo Jakob6, Holger Schulz7, Heidrun Behrendt2,3, Johannes Ring1,2, Martin Hrabé de Angelis8, Dirk H. Busch4,5, Martin Mempel1,2,* and Markus Ollert1,*

1 Department of Dermatology and Allergy, Biederstein, Technische Universität München, and Clinical Research Division of Molecular and Clinical Allergotoxicology, Technische Universität München, Munich; 2 Division of Environmental Dermatology and Allergy TUM/ Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg; 3 Focus Network Nanoparticles and Health (NanoHealth), Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg; 4 Institute of Microbiology, Immunology, and Hygiene, Technische Universität München, Munich; 5 Clinical Cooperation Groups ‘Antigen-Specific Immunotherapy’ and ‘Immune-Monitoring’, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg and Technische Universität München, Munich; 6 Allergy Research Group, University Medical Center Freiburg, Freiburg; 7 Institute for Inhalation Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg; and 8 Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany

Correspondence and requests for reprints should be addressed to Prof. Markus Ollert, M.D., Department of Dermatology and Allergy, Biederstein Technische Universität München Biedersteiner Str. 29 D-80802 München, Germany. E-mail: ollert{at}lrz.tum.de

Rationale: Studies in humans and rodents have indicated a causative role for CD8+ T cells in IgE-mediated allergic inflammation, but their function is still controversial.

Objectives: To analyze the role of allergen-specific CD8+ T cells during the development of allergic airway inflammation in two parallel but diverging outcome models.

Methods: We used H2-Kb SIINFEKL (OVA257–264) multimers to analyze induction, natural distribution, and phenotype of allergen-specific CD8+ T cells in a murine C57BL/6 model of ovalbumin (OVA)-induced allergic airway inflammation using low-dose or high-dose OVA sensitization.

Measurements and Main Results: The low-dose protocol was characterized by a significant induction of total and OVA-specific IgE, eosinophilic airway inflammation, IL-4 levels in bronchoalveolar lavage fluid. And significant alterations in lung function. The high dose protocol was characterized by a significant reduction of the allergic phenotype. Using OVA257–264 H2-Kb multimers, we observed lung and airway infiltrating OVA-specific CD8+ T cells showing an effector/effector-memory phenotype. The high-dose protocol caused significantly higher infiltration of allergen-specific CD8+ cells to the airways and enhanced their cytotoxicity. Adoptive transfer with CD8+ T cells from transgenic OT-I mice to TAP1–/– or wild-type mice showed their migration to the lungs and TAP1-dependent proliferation after OVA-aerosol exposure. TAP1–/– mice defective in CD8+ T cells showed exacerbated symptoms in the low-dose sensitization model.

Conclusions: Allergen-specific CD8+ T cells seem to protect from allergic inflammation in the lungs. Their number, which is dependent on the sensitization dose, appears to be a critical predictor for the severity of the allergic phenotype.

Key Words: cytotoxicity • tolerance • airway inflammation • asthma • immunotherapy


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Previous studies have indicated a divergent role for specific CD8+ T cells in allergic airway disease. To address this controversy, opposing priming conditions for CD8+ T cells using high- or low-dose allergen concentrations were applied.

What This Study Adds to the Field
The recruitment of functionally active allergen-specific CD8+ T cells to the airways, which is dependent on the allergen sensitization dose, appears to be a critical predictor for the severity of the allergic phenotype in mice.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2010 American Thoracic Society
  Red In Translatin